Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

ClinicalTrials.gov ID: NCT06492291

Public ClinicalTrials.gov record NCT06492291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia

Study identification

NCT ID
NCT06492291
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
3,000 participants

Conditions and interventions

Interventions

  • Enlicitide Decanoate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 4, 2024
Primary completion
Oct 12, 2028
Completion
Oct 12, 2028
Last update posted
Oct 6, 2025

2024 – 2028

United States locations

U.S. sites
52
U.S. states
27
U.S. cities
51
Facility City State ZIP Site status
Alliance for Multispecialty Research, LLC ( Site 0027) Daphne Alabama 36526
G&L Research ( Site 0035) Foley Alabama 36535
Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048) Phoenix Arizona 85020
National Heart Institute-Research ( Site 0029) Beverly Hills California 90211
Clinical Trials Research ( Site 0054) Sacramento California 95821
Velocity Clinical Research, Banning ( Site 0023) San Bernardino California 92408
Emerson Clinical Research Institute ( Site 0017) Washington D.C. District of Columbia 20009
Excel Medical Clinical Trials ( Site 0010) Boca Raton Florida 33434
Alliance for Multispecialty Research, LLC ( Site 0037) Doral Florida 33172
Alliance for Multispecialty Research, LLC ( Site 0056) Fort Myers Florida 33912
Velocity Clinical Research, Hallandale Beach ( Site 0053) Hallandale Florida 33009
Jacksonville Center for Clinical Research ( Site 0025) Jacksonville Florida 32216
South Broward Research ( Site 0012) Miramar Florida 33027
Progressive Medical Research ( Site 0033) Port Orange Florida 32127
Clinical Research Trials of Florida ( Site 0006) Tampa Florida 33607
Clinical Site Partners, LLC dba Flourish Research ( Site 0004) Winter Park Florida 32789
East Coast Institute for Research, LLC ( Site 0020) Macon Georgia 31210
Healthcare Research Network - Chicago ( Site 0051) Flossmoor Illinois 60422
Synexus Clinical Research US - Evansville ( Site 0005) Evansville Indiana 47714
Midwest Institute For Clinical Research ( Site 0052) Indianapolis Indiana 46260
Alliance for Multispecialty Research, LLC ( Site 0001) Lexington Kentucky 40509
L-MARC Research Center ( Site 0011) Louisville Kentucky 40213
Velocity Clinical Research, Covington ( Site 0026) Covington Louisiana 70433
Velocity Clinical Research Rockville ( Site 0022) Rockville Maryland 20854
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0018) Troy Michigan 48098
Velocity Clinical Research, Gulfport ( Site 0032) Gulfport Mississippi 39503
Healthcare Research Network - St. Louis ( Site 0040) Hazelwood Missouri 63042
Velocity Clinical Research at The Pioneer Heart Institute, Lincoln ( Site 0031) Lincoln Nebraska 68510
Jubilee Clinical Research ( Site 0049) Las Vegas Nevada 89106
AB Clinical Trials ( Site 0002) Las Vegas Nevada 89119
New Mexico Clinical Research & Osteoporosis Center ( Site 0043) Albuquerque New Mexico 87106
Velocity Clinical Research, Syracuse ( Site 0014) East Syracuse New York 13057
Icahn School of Medicine at Mount Sinai-Cardiology ( Site 0042) New York New York 10029
Lillestol Research ( Site 0030) Fargo North Dakota 58104
altoona center for clinical research ( Site 0024) Duncansville Pennsylvania 16635
Cardiology Consultants of Philadelphia Yardley ( Site 0021) Yardley Pennsylvania 19067
Velocity Clinical Research, Anderson ( Site 0015) Anderson South Carolina 29621
Piedmont Research Partners ( Site 0045) Fort Mill South Carolina 29707
Coastal Carolina Research Center ( Site 0055) North Charleston South Carolina 29405
Monument Health Clinical Research, a department of Monument -Monument Health Clinical Research, a d ( Site 0038) Rapid City South Dakota 57701
Holston Medical Group ( Site 0034) Kingsport Tennessee 37660
Alliance for Multispecialty Research, LLC ( Site 0050) Knoxville Tennessee 37920
Velocity Clinical Research, Dallas ( Site 0028) Dallas Texas 75230
Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0009) Houston Texas 77030
Clinical Trials of Texas, LLC ( Site 0016) San Antonio Texas 78229
Synexus Clinical Research US, Inc. ( Site 0003) Salt Lake City Utah 84106
Velocity Clinical Research, Salt Lake City ( Site 0041) West Jordan Utah 84088
Manassas Clinical Research Center ( Site 0007) Manassas Virginia 20110
Health Research of Hampton Roads, Inc. ( Site 0019) Newport News Virginia 23606
Alliance for Multispecialty Research, LLC ( Site 0008) Norfolk Virginia 23502
National Clinical Research, Inc ( Site 0044) Richmond Virginia 23294
Rainier Clinical Research Center ( Site 0013) Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 170 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06492291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06492291 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →